Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Gorlice

5 clinical trials in Gorlice, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Gorlice at a glance
5
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Gorlice

Open in trial search
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:SELTOREXANT
  • Sponsor:Janssen - Cilag International
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Iti-1284
  • Sponsor:Intra-Cellular Therapies Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Mk-1084
  • Sponsor:Merck Sharp & Dohme LLC

Cognitive disorder+1

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:(2R,3S)-2-Amino-3-Hydroxy-3-Pyridin-4-Yl-1-Pyrrolidin-1-Ylpropan-1-One (2R,3R)-2,3-Dihydroxybutanedioic Acid
  • Sponsor:Recognify Life Sciences Inc.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Gorlice

What the registry says about research in the country

01 Mental Health Studies

Innovative research focusing on Major Depressive Disorder with concurrent insomnia symptoms, evaluating new combination therapies alongside existing antidepressants for enhanced treatment outcomes.

  • Depression with Insomnia
  • Antidepressant Augmentation
  • Treatment Resistance

These trials aim to improve therapeutic responses in patients who haven't achieved adequate results with standard treatments.

02 Anxiety Disorders

Clinical investigations examining new therapeutic approaches for Generalized Anxiety Disorder, testing innovative adjunctive treatments to enhance current GAD management strategies.

  • Anxiety Management
  • Combination Therapy
  • Treatment Enhancement

Research focused on developing more effective treatment options for patients with inadequate response to standard anxiety medications.

03 Neurological Research

Groundbreaking studies addressing cognitive impairment in schizophrenia patients, exploring novel therapeutic compounds to enhance cognitive function and overall quality of life.

  • Cognitive Enhancement
  • Schizophrenia Treatment
  • Mental Function

Specialized research targeting the cognitive aspects of schizophrenia through innovative therapeutic approaches.

04 Oncology Studies

Advanced research in Non-small Cell Lung Cancer treatment, evaluating combination therapies with pembrolizumab for metastatic squamous NSCLC patients.

  • Lung Cancer Treatment
  • Immunotherapy
  • Maintenance Therapy

Cutting-edge trials focusing on improving survival outcomes in treatment-naïve metastatic lung cancer patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.